Fecal Calprotectin Levels Are Closely Correlated with the Absence of Relevant Mucosal Lesions in Postoperative Crohn's Disease

Garcia-Planella, Esther; Mañosa, Míriam; Cabré, Eduard; More

Inflammatory Bowel Diseases . 22(12):2879-2885, December 2016.

High Within-day Variability of Fecal Calprotectin Levels in Patients with Active Ulcerative Colitis: What Is the Best Timing for Stool Sampling?

Calafat, Margalida; Cabré, Eduard; Mañosa, Míriam; More

Inflammatory Bowel Diseases . 21(5):1072-1076, May 2015.

Long-term Comparative Efficacy of Cyclosporine- or Infliximab-based Strategies for the Management of Steroid-refractory Ulcerative Colitis Attacks

Naves, Juan E.; Llaó, Jordina; Ruiz-Cerulla, Alexandra; More

Inflammatory Bowel Diseases . 20(8):1375-1381, August 2014.

Addition of Metronidazole to Azathioprine for the Prevention of Postoperative Recurrence of Crohn’s Disease: A Randomized, Double-Blind, Placebo-Controlled Trial

Mañosa, Míriam; Cabré, Eduard; Bernal, Isabel; More

Inflammatory Bowel Diseases . 19(9):1889-1895, August 2013.

Safety of Thiopurine Therapy in Inflammatory Bowel Disease: Long-term Follow-up Study of 3931 Patients

Chaparro, María; Ordás, Ingrid; Cabré, Eduard; More

Inflammatory Bowel Diseases . 19(7):1404-1410, June 2013.

Tuberculous chemoprophylaxis requirements and safety in inflammatory bowel disease patients prior to anti‐TNF therapy

Zabana, Yamile; Domènech, Eugeni; San Román, Antonio López; More

Inflammatory Bowel Diseases . 14(10):1387-1391, October 2008.

Impact of azathioprine on the prevention of postoperative Crohn's disease recurrence: Results of a prospective, observational, long‐term follow‐up study

Domènech, Eugeni; Mañosa, Míriam; Bernal, Isabel; More

Inflammatory Bowel Diseases . 14(4):508-513, April 2008.

Determinants of Plasma Fatty Acid Abnormalities in Patients with Active Inflammatory Bowel Disease: A Multivariate Analysis

Esteve-Comas, Maria; Ramirez, María; Fernández-Bañares, Fernando; More

Inflammatory Bowel Diseases . 1(2):95-100, Summer 1995.